enVVeno Medical Corporation (NVNO) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$502
Total Return
-94.98%
CAGR
-45.02%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -1.43% |
| Median | -3.82% |
| Best | +98.49% |
| Worst | -84.57% |
| % of Windows Positive | 41.9% |
1-Year (252 Trading Days)
| Average | -27.70% |
| Median | -23.86% |
| Best | +97.77% |
| Worst | -92.90% |
| % of Windows Positive | 17.3% |
3-Year (756 Trading Days)
| Average | -56.17% |
| Median | -58.09% |
| Best | +20.76% |
| Worst | -96.00% |
| % of Windows Positive | 6.0% |
Risk Metrics
| Maximum Drawdown | -97.66% |
| Average Drawdown | -57.11% |
| Drawdown Duration | 1175 Trading Days (Unrecovered) |
| Sortino Ratio | -0.34 |
| Calmar Ratio | -0.46 |
| CVaR (5%) | -11.19% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | -4.65% (-10.69% ann.) | $465.31 | $0.00 | $0.00 | $0.00 |
| 2025 | -89.37% | $8937.23 | $0.00 | $0.00 | $0.00 |
| 2024 | -41.25% | $4124.68 | $0.00 | $0.00 | $0.00 |
| 2023 | +0.79% | +$78.60 | $0.00 | $0.00 | $0.00 |
| 2022 | -22.61% | $2261.01 | $0.00 | $0.00 | $0.00 |
| 2021 | -23.82% | $2381.61 | $0.00 | $0.00 | $0.00 |
| 2020 | -37.09% | $3709.06 | $0.00 | $0.00 | $0.00 |
| 2019 | -62.71% | $6271.19 | $0.00 | $0.00 | $0.00 |
| 2018 partial | -71.85% (-88.51% ann.) | $7185.11 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | May 31, 2018 – February 19, 2020 | -86.26% | -68.42% | $8625.95 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -58.33% | -100.00% | $5833.28 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +16.79% | +28.36% | +$1678.68 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | -15.57% | -14.83% | $1556.79 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -15.07% | -15.93% | $1507.48 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -8.90% | -4.91% | $890.31 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -94.00% | -80.78% | $9399.96 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.